The current cohort study of 300 stable COPD patients aims to assess the following topics: * The prevalence of anxiety and depressive disorders in patients with COPD * The screening properties of Hospital Anxiety and Depression Scale in patients with COPD * The prognostic influence by anxiety or depressive symptoms and anxiety or depressive disorder. * whether characterization of 1) affective aspects of dyspnea symptoms or 2) persistent styles of thinking (worry or rumination) and metacognitions that drive these may improve the current recommendation of screening for anxiety and depression in COPD in relation to its clinical relevance on functional status and three year outcome
Study Type
OBSERVATIONAL
Enrollment
200
LHL-hospital Gardermoen
Jessheim, Norway
COPD exacerbation rate
The number of moderate or severe exacerbations
Time frame: 3 years
Mortality rate
The number of deaths
Time frame: 3 years
Assessment of Health-related Quality of Life With RAND-36
The total score and subscale scores on RAND 36
Time frame: 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.